ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "fibromyalgia and pain management"

  • Abstract Number: 74 • ACR/ARHP Annual Meeting 2015

    Clinical Characteristics of Fibromyalgia in a Chronic Pain Population

    Mark Gostine1, Fred Davis1, Bradley Roberts2, Rebecca Risko2, Joseph Cappelleri3, Michael Asmus4, Andrew Clair5 and Alesia Sadosky6, 1Michigan Pain Consultants, PC, Grand Rapids, MI, 2ProCare Systems, Inc., Grand Rapids, MI, 3Biostatistics, Pfizer, Inc., Groton, CT, 4North American Medical Affairs, Pfizer, Inc., Middleton, WI, 5Pfizer Inc., New York, NY, 6Pfizer Inc,, New York, NY

    Background/Purpose: The study’s purpose was to advance the understanding and treatment of fibromyalgia (FM) for patients in a chronic pain management center.  FM is a…
  • Abstract Number: 916 • ACR/ARHP Annual Meeting 2015

    Assessing Alternative Selection Criteria for Fibromyalgia Patients within a Multicenter Chronic Pain Claims Database

    Mark Gostine1, Fred Davis1, Bradley Roberts2, Rebecca Risko2, Joseph Cappelleri3, Michael Asmus4, Andrew Clair5 and Alesia Sadosky6, 1Michigan Pain Consultants, PC, Grand Rapids, MI, 2ProCare Systems, Inc., Grand Rapids, MI, 3Biostatistics, Pfizer, Inc., Groton, CT, 4North American Medical Affairs, Pfizer, Inc., Middleton, WI, 5Pfizer Inc., New York, NY, 6Pfizer Inc,, New York, NY

    Background/Purpose: Diagnosing FM is difficult because there is no specific laboratory test to confirm the disorder. Billing practices dictate that physicians assign ICD-9-CM (Corresponding International…
  • Abstract Number: 1109 • ACR/ARHP Annual Meeting 2013

    Which Baseline Characteristics Influence The Response To Milnacipran  In Patient With Fibromyalgia ?

    Olivier Vitton1, Olivier Vitton1, Pierre Bunouf2, Lilia Abtroun3 and Frederic Bonfils1, 1Pierre Fabre, Castres, France, 2Pierre Fabre, Toulouse, France, 3Ariana Pharma, Paris, France

    Background/Purpose: Milnacipran (MLN) has demonstrated its benefit in treating patients with fibromyalgia. Fibromyalgia is a persistent pain condition that aggregates numerous symptoms (pain, fatigue, sleep…
  • Abstract Number: L6 • ACR/ARHP Annual Meeting 2013

    Efficacy and Safety of Pregabalin in Patients with Fibromyalgia and Co-Morbid Depression Receiving Concurrent Antidepressant Therapy: A Randomized, 2-Way Crossover, Double-Blind, Placebo-Controlled Study

    Lesley M. Arnold1, Piercarlo Sarzi-Puttini2, Pierre Arsenault3, Tahira Khan4, Pritha Bhadra Brown5, Andrew Clair5, Joseph Driscoll4, Jaren Landen4 and Lynne Pauer4, 1Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, 2Azienda Ospedaliera Polo Universitario L. Sacco, Milano, Italy, 3Département de Médecine de Famille, Université de Sherbrooke, Sherbrooke, QC, Canada, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, New York, NY

    Background/Purpose: Fibromyalgia (FM) is characterized by chronic widespread pain and often associated with mood disorders including depression. Approximately 50–70% of FM patients have a lifetime…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology